Joshua Richter, MD, discusses long-term follow up data findings for multiple myeloma and their implications on front-line therapy options for patients.
ASH 2020 Post Conference Perspectives: Updates in Multiple Myeloma
An expert in the management of multiple myeloma discusses new data released from the GRIFFIN trial as well as real-world evidence regarding frontline autologous stem cell transplantation.
Joshua Richter, MD, provides an overview of new data from various trials presented at ASH 2020 regarding newly diagnosed patients with multiple myeloma.
An expert looks to the future directions in multiple myeloma and discusses upcoming advances in the field.
Advertisement
Advertisement
Trending on AJMC
1
Energy Insecurity Linked to Higher Depression, Anxiety in US Adults
2
FDA Expands Sotatercept Indication for PAH
3
Patients, Providers Strongly Favor Oral Therapies in Psoriasis
4
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
5
